Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis

Gynecological Endocrinology

Volumn 20, Issue 3, 2005, Pages 127-131

  Maia Jr , Hugo ^a   Maltez, Amélia ^a   Studart, Eduardo ^b   Athayde, Célia ^a   Coutinho, Elsimar M ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Adenomyosis; Apoptosis; Bcl 2; Ki 67; Mirena

Indexed keywords

KI 67 ANTIGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PROTEIN BCL 2; STEROID HORMONE;

ADENOMYOSIS; ADULT; ARTICLE; CELL PROLIFERATION; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; INTRAUTERINE CONTRACEPTIVE DEVICE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; APOPTOSIS; CELL DIVISION; CONTRACEPTIVES, ORAL; ENDOMETRIOSIS; FEMALE; FOLLICULAR PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEVONORGESTREL; LUTEAL PHASE; MENSTRUAL CYCLE; MIDDLE AGED; OVULATION; PARAFFIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TISSUE EMBEDDING;

EID: 18844412182     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400021086     Document Type: Article

References (16)

1. Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from dislocation of basal endometrium. Hum Reprod 2002;17:2725-2736.
2. Yananoto T, Noguchi T, Tamura T, Kitawaki J, Okada H. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993;169:734-738.
3. Mertens HJ, Heineman MJ, Evers JL. The expression of apoptosis-related proteins Bcl-2 and Ki-67 in endometrium of ovulatory menstrual cycle. Gynecol Obstet Invest 2002;53:375-382.
4. Fedele L, Bianchi S, Raffaeli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-429.
5. Maia H Jr, Maltez A, Coelho G, Athayde C, Coutinho EM. Insertion of Mirena® after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10:512-516.
6. Maruo T, Laog-Fernandez P, Pakarinen P, Murakoshi H, Spitz IM, Johanson E. Effects of levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod 2001;16:2103-2108.
7. Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. Apoptosis in human endometrial and endometriotic tissues. Horm Res 1997;48(Suppl 3):42-47.
8. Zhang L, Li J, Li M. Expression of bcl-2 protein in adenomyosis. Zhonghua Fu Chan Ke Za Zhi 2000;35:533-535.
9. Huang F, Lin QH, Liu FY, Zhong ZS. Expression of bcl-2 in normal endometrium and endometrium of adenomyosis. Human Yi Ke Da Xue Xue Bao 2000;25:453-456.
10. Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999;94:71-77.
11. Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of secretory phase. J Clin Endocrinol Metab 1999;84:1737-1743.
12. Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intra-uterine system. Contraception 1999;60:173-176.
13. von Rango U, Classen-Linke I, Krusche CA, Beier HM. The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 1998;13:3177-3189.
14. Ikomi A, Pepra EF. Efficacy of levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities. J Fam Plann Reprod Health Care 2002;28:99-100.
15. Goswami A, Khemani M, Logani KB, Amand R. Adenomyosis: diagnosis by hysteroscopic endo-myometrial biopsy; correlation of incidence and severity with menorrhagia. J Obstet Gynaecol Res 1998;24:281-291.
16. Falk RJ, Mullin BR. Exacerbation of adenomyosis symptomatology by estrogen-progestin therapy: a case report and histopathological observations. Int J Fertil 1989;34:386-389.